Pre-transplant anti-fibrotics for idiopathic pulmonary fibrosis: Are we seeing a new role for the anti-fibrotics?

被引：0
|
作者：
Prasad, Jyotika D. [1 ,2 ]
Snell, Gregory I. [1 ,2 ]
机构：
[1] Alfred Hosp, Lung Transplant Serv, Melbourne, Vic, Australia
[2] Monash Univ, Melbourne, Vic, Australia
来源：
RESPIROLOGY | 2024年 / 29卷 / 01期
关键词：
anti-fibrotic agents; disease progression; idiopathic; lung transplantation; pulmonary fibrosis; respiratory function tests; vital capacity; LUNG TRANSPLANTATION; PIRFENIDONE;
D O I：
10.1111/resp.14614
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
See related article
引用
收藏
页码：16 / 17
页数：2
相关论文
共 31 条
  • [1] Anti-fibrotics as novel therapy for idiopathic pulmonary fibrosis
    Funke-Chambour, Manuela
    Geiser, Thomas
    THERAPEUTISCHE UMSCHAU, 2016, 73 (01) : 25 - 29
  • [2] Cost-effectiveness of the anti-fibrotics for the treatment of idiopathic pulmonary fibrosis in the United States
    Dempsey, Timothy M.
    Thao, Viengneesee
    Moriarty, James P.
    Borah, Bijan J.
    Limper, Andrew H.
    BMC PULMONARY MEDICINE, 2022, 22 (01)
  • [3] Cost-effectiveness of the anti-fibrotics for the treatment of idiopathic pulmonary fibrosis in the United States
    Timothy M. Dempsey
    Viengneesee Thao
    James P. Moriarty
    Bijan J. Borah
    Andrew H. Limper
    BMC Pulmonary Medicine, 22
  • [4] PATIENT STORIES: THE USE OF NOVEL ANTI-FIBROTICS, PIRFENIDONE AND NINTEDANIB, IN THE MANAGEMENT OF IDIOPATHIC PULMONARY FIBROSIS, IPF
    Enston-Newall, S.
    THORAX, 2017, 72 : A247 - A248
  • [5] Muscle fibrosis in the soft palate: Delivery of cells, growth factors and anti-fibrotics
    Von den Hoff, Johannes W.
    Monroy, Paola L. Carvajal
    Ongkosuwito, Edwin M.
    van Kuppevelt, Toin H.
    Daamen, Willeke F.
    ADVANCED DRUG DELIVERY REVIEWS, 2019, 146 : 60 - 76
  • [6] Impact of topical anti-fibrotics on corneal nerve regeneration in vivo
    Hindman, Holly B.
    DeMagistris, Margaret
    Callan, Christine
    McDaniel, Thurma
    Bubel, Tracy
    Huxlin, Krystel R.
    EXPERIMENTAL EYE RESEARCH, 2019, 181 : 49 - 60
  • [7] Real-World Evaluation of the Impact of the Anti-fibrotics in Patients with Idiopathic Pulmonary Fibrosis and Other Fibrotic Lung Diseases
    Dempsey, T. M.
    Thao, V.
    Sangaralingham, L.
    Limper, A. H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [8] Mortality Effect of the Anti-Fibrotics Pirfenidone and Nintedanib in Clinical Practice
    Dempsey, T. M.
    Sangaralingham, L.
    Yao, X.
    Limper, A. H.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 199
  • [9] Risk of anastomotic dehiscence in patients with pulmonary fibrosis transplanted while receiving anti-fibrotics: Experience of the Australian Lung Transplant Collaborative
    Mackintosh, John A.
    Munsif, Maitri
    Ranzenbacher, Lucy
    Thomson, Claire
    Musk, Michael
    Snell, Gregory
    Glanville, Allan
    Chambers, Daniel C.
    Hopkins, Peter
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2019, 38 (05): : 553 - 559
  • [10] Anti-fibrotics/steroidsFatigue, cervical lymph node swelling, diarrhoea and lack of efficacy
    Reactions Weekly, 2024, 2020 (1) : 52 - 52
1234